Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 22:11:421.
doi: 10.3389/fneur.2020.00421. eCollection 2020.

Effects of Probiotics on Depressive or Anxiety Variables in Healthy Participants Under Stress Conditions or With a Depressive or Anxiety Diagnosis: A Meta-Analysis of Randomized Controlled Trials

Affiliations

Effects of Probiotics on Depressive or Anxiety Variables in Healthy Participants Under Stress Conditions or With a Depressive or Anxiety Diagnosis: A Meta-Analysis of Randomized Controlled Trials

Limin Chao et al. Front Neurol. .

Abstract

Background: Probiotics have been associated with the treatment of depression and anxiety. However, the results reported in the literature have been inconsistent, and no meta-analysis specifically reported probiotics used on participants with varying levels of emotional state. Methods: This meta-analysis aimed to study the effectiveness of probiotics on anxious or depressive symptomatology for participants under stress conditions or with a depressive or anxiety disorder diagnosis. Medline, PubMed, EMBASE, and the Cochrane Library were searched through December 2019 for randomized controlled trials (RCTs). The primary outcomes were depression and anxiety scores. Main inclusion criteria: RCTs of probiotics for participants with a mood or emotional disorder diagnosis or under stress situations; and all participants were adults (age ≥16 years); Assessed by the modified Jadad assessment scale found seven high-quality studies and three low-quality studies. Results: Ten clinical trials (n = 685 total participants) were included based on the inclusion and exclusion criteria. All studies were assessed as low or moderate risk of bias. The meta-analysis showed that probiotics could significantly reduce the depression scale for patients with anxiety and depression, and healthy participants under stress. However, there was no significant difference between the probiotics and placebo groups in the reduction of patient anxiety scores, even if they are depressive or anxious patients or healthy participants under stress. Subgroup analysis revealed that probiotics had significant effect on depressive symptoms just in patients with depression, and no significant change in anxiety in patients, and no improvement in participant performance under stress. Conclusions: Probiotics could alleviate depressive symptoms in patients with a depression diagnosis or depression scores also in anxiety disorder diagnosis, and suggesting that probiotics may be adjunct therapies for mood or emotional disorders. Therefore, it is essential that probiotics could be more involved in the treatment of patients with depression in the future. The evidence of probiotics successfully treating depression is still insufficient, and more high-quality studies on patients with depression are still needed.

Keywords: anxiety; depression; meta-analysis; probiotics; under stress.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA flowchart showing the study and selection process of the literature.
Figure 2
Figure 2
(A) Forest plots for depression status. (B) Forest plots for anxiety status.
Figure 3
Figure 3
(A) Forest plot showing depressive symptoms of probiotics in patients with depression or anxiety. (B) Forest plot showing anxiety symptoms of probiotics in patients with depression or anxiety.
Figure 4
Figure 4
(A) Forest plot showing subgroup analysis of depression in individuals with under stress. (B) Forest plot showing subgroup analysis of anxiety in individuals with under stress.
Figure 5
Figure 5
(A) Funnel plot of depression. (B) Funnel plot of anxiety.

References

    1. World Health Organization Depression and Other Common Mental Disorders: Global Health Estimates (2017).
    1. Lim GY, Tam WW, Lu YX, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. (2018) 8:2681. 10.1038/s41598-018-21243-x - DOI - PMC - PubMed
    1. Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. (2013) 43:897–910. 10.1017/S003329171200147X - DOI - PubMed
    1. Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA. The global burden of anxiety disorders in 2010. Psychol Med. (2014) 44:2363–74. 10.1017/S0033291713003243 - DOI - PubMed
    1. Reis DJ, Ilardi SS, Punt SEW. The anxiolytic effect of probiotics: a systematic review and meta-analysis of the clinical and preclinical literature. PLoS ONE. (2018) 13:e0199041. 10.1371/journal.pone.0199041 - DOI - PMC - PubMed

Publication types